Canada-based laboratory software company GenoLogics secured $8m of series D funding on Thursday in a round led by biotechnology analysis firm Illumina.

GenoLogics raised $5m in series C financing, in February 2009, from venture capital firm OVP Venture Partners, Yaletown Venture Partners and Growthworks Capital, all of which also invested in GenoLogics’ 2006 series B round. OVP originally provided $3.1m in series A financing in February 2005.

The funding follows Genologics’ signing of a global co-selling agreement with Illumina in February to market a version of Genologics’ laboratory information managent system pre-configured for Illumina’s instruments and sample preparation kits.

Tristan Orpin, senior vice-president at Illumina, said: "This strategic investment in GenoLogics will benefit our mutual sequencing customers. We value the unique data management capabilities GenoLogics brings to our customers and the industry."

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?